Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
High-risk metastatic gestational trophoblastic tumors: Current management
John Robert Lurain III
*
*
Corresponding author for this work
Obstetrics and Gynecology
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'High-risk metastatic gestational trophoblastic tumors: Current management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
metastases
100%
chemotherapy
100%
patients
66%
risks
50%
surgery
33%
tumors
33%
diseases
33%
doses
33%
methotrexate
33%
therapy
16%
brain
16%
management
16%
infusion
16%
lungs
16%
radiotherapy
16%
central nervous system
16%
irradiation
16%
bleomycin
16%
cyclophosphamide
16%
world health organization
16%
vagina
16%
actinomycin
16%
Medicine and Dentistry
Patient
100%
Diseases
33%
Drug Megadose
33%
Metastatic Carcinoma
33%
Gestational Trophoblastic Disease
33%
Methotrexate
33%
Etoposide
33%
Surgery
16%
Surgical Technique
16%
Thoracotomy
16%
Survival Rate
16%
Cyclophosphamide
16%
Vincristine
16%
Dactinomycin
16%
Infusion
16%
Combination Therapy
16%
Adjuvant Radiotherapy
16%
Hysterectomy
16%
Chemotherapy Regimens
16%
Bleomycin
16%
Cisplatin
16%
Brain Radiation
16%
Combination Chemotherapy
16%
Central Nervous System Metastasis
16%
Therapeutic Procedure
16%
Lung
16%
Vagina
16%
Nursing and Health Professions
Chemotherapy
66%
Diseases
33%
Metastasis
33%
Drug Megadose
33%
Methotrexate
33%
Trophoblastic Tumor
33%
Etoposide
33%
Inpatient
33%
Thoracotomy
16%
Survival Rate
16%
Surgical Technique
16%
Surgery
16%
Hysterectomy
16%
Combination Therapy
16%
Infusion
16%
Cyclophosphamide
16%
Vincristine
16%
World Health Organization
16%
Combination Chemotherapy
16%
Bleomycin
16%
Adjuvant Radiotherapy
16%
Cisplatin
16%
Dactinomycin
16%
Brain Radiation
16%
Central Nervous System Metastasis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
33%
Methotrexate
33%
Trophoblastic Tumor
33%
Metastasis
33%
Etoposide
33%
Survival Rate
16%
Cyclophosphamide
16%
Dactinomycin
16%
Bleomycin
16%
Cisplatin
16%
Vincristine
16%
Central Nervous System Metastasis
16%